Home exposure to moisture and mold is associated with poorer asthma control in children: CHAMPIASTHMA study

Margaux Sauvere1, Stéphanie Lejeune1,2, Flore Chagnon1,3

  • 1Pediatric Pulmonology and Allergy Department, Jeanne de Flandre Hospital, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.

Abstract

Insights

Exposure to moisture and/or mold (EMM) in indoor environments is linked to worse asthma control in children. Healthcare providers should systematically check for EMM in children with uncontrolled asthma.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Indoor environmental quality is a significant factor influencing childhood asthma control.
  • Poorly controlled asthma in children is often associated with detrimental indoor environments.

Purpose of the Study:

  • To investigate the association between exposure to moisture and/or mold (EMM) and the level of asthma control in pediatric patients.
  • To evaluate the impact of EMM on various asthma-related outcomes in children.

Main Methods:

  • The CHAMPIASTHMA study employed a multicenter, cross-sectional observational design.
  • Asthma control was assessed using Global Initiative on Asthma guidelines and validated asthma control tests.
  • Exposure to moisture and/or mold (EMM) was determined via a parent-administered questionnaire for children aged 1-17 years with recurrent wheeze or asthma.

Main Results:

  • Children with EMM exhibited significantly poorer asthma control as per Global Initiative on Asthma guidelines (45% vs 33%, P=.03).
  • Patients exposed to EMM reported lower Asthma Control Test scores (22 vs 24, P=.02) and experienced more frequent unscheduled visits (45% vs 32%, P=.02).
  • A trend towards higher oral corticosteroid use was observed in children with EMM (37% vs 27%, P=.09), though hospitalization rates and asthma treatment steps did not differ.

Conclusions:

  • Exposure to moisture and/or mold (EMM) is demonstrably associated with diminished asthma control and adverse outcomes in children.
  • Routine screening for EMM during clinical visits is recommended, particularly for children presenting with uncontrolled asthma symptoms.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
201
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K